Clinical Trials Browser

Phase 2 × FED × Epirubicin × Clear all

NCT00218205 2005-09-22

A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

Phase 2 Unknown

Prostatic Neoplasms